Indeed, the humanized anti-CD6 SRCR-D1 clone T1h which does not interfere with the CD6-ALCAM interactions may have therapeutic implications in oncology, transplantation, and autoimmunity. This evidence concerns the gene CD6 and Autoimmunity.